BTAI BioXcel Therapeutics, Inc.

$1.20 +0.42%

Healthcare · Pharmaceutical Preparations

BioXcel Therapeutics, Inc. (BTAI) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $37 million. Shares last traded at $1.20, 85.1% below their 52-week high. Over the past year the stock is down 25.9%. Net profit margin is -10887.4%, below the peer median of -0.1%. Revenue declined 71.7% year over year.

Market Cap

$37M

Shares Out

30.9M

EPS (TTM)

$-12.59

P/E Ratio

—

P/S Ratio

57.72

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.05

52-Week Low

$1.01

Volume

26,115

Avg Vol (3m)

37,140.984

Performance

+6.19%

+11.11%

-25.00%

-36.51%

YTD

-29.41%

-25.93%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

53.25

SMA (50)

$1.16

SMA (200)

$1.79

Price vs SMA50

+3.71%

Price vs SMA200

-33.05%

ATR (14)

$0.07

Financials

Revenue

$1M

Net Income

$-70M

Gross Margin

—

Operating Margin

-7860.0%

Net Margin

-10887.4%

Return on Equity

66.2%

Return on Assets

-205.4%

Current Ratio

0.62

Debt / Equity

-0.95

Revenue Growth (YoY)

-71.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.54	2026-05-15
FY 2025	$-5.73	2026-03-27
Q3 2025	$-6.38	2025-11-12
Q2 2025	$-4.17	2025-08-12
Q1 2026	$-1.50	2026-05-15
FY 2025	$-23.51	2026-03-27

Full earnings history →

Pharmaceutical Preparations peers

BTAI vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

57.72 / 3.54 med

+1531% premium

Net margin vs peers

-10887.4% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.